66
Views
0
CrossRef citations to date
0
Altmetric
Research Highlights

Epigenomics and Targeted Therapy in Cancer

&
Pages 571-575 | Published online: 22 Dec 2014

References

  • Gray-Schopfer V , WellbrockC , MaraisR . Melanoma biology and new targeted therapy . Nature445 , 851 – 857 ( 2007 ).
  • Hadnagy A , BeaulieuR , BalickiD . Histone modifications and noncanonical functions of histones: perspectives in cancer epigenetics . Mol. Cancer Ther.7 , 740 – 748 ( 2008 ).
  • alentini A , GravinaP , FedericiGet al. Valporic acid induces apoptosis, p16INK4A upregulation and sensitization to chemotherapy in human melanoma cells . Cancer Biol. Ther.6 , 185 – 191 ( 2007 ).
  • Schipper H , AllaV , MeierCet al. Eradication of metastatic melanoma through cooperative expression of RNA-based HDAC1 inhibitor and p73 by oncolytic adevirus . Oncotarget5 ( 15 ), 5893 – 5907 ( 2014 ).
  • Gong JG , CostanzoA , YangHQet al. The tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage . Nature399 , 806 – 809 ( 1999 ).
  • Jones PA , BaylinSB . The fundamental role of epigenetic events in cancer . Nat. Rev. Genet.3 , 415 – 428 ( 2002 ).
  • De Smet C , LoriotA . DNA hypomethylation and activation of germline-specific genes in cancer . Adv. Exp. Med. Biol.754 , 149 – 166 ( 2013 ).
  • Loriot A , Van TonglenA , BlancoJet al. A novel cancer-germline transcript carrying pro-metastatic miR-105 and TET-targeting miR-767 induced by DNA hypomethylation in tumors . Epigenetics9 ( 8 ), 1163 – 1171 ( 2014 ).
  • Zhou W , FongMY , MinYet al. Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis . Cancer Cell25 , 501 – 515 ( 2014 ).
  • Pfeifer GP , KadamS , JinSG . 5-Hydroxymethylcytosine and its potential roles in development and cancer . Epigenetics Chromatin6 , 10 ( 2013 ).
  • Ito S , D’AlessioAC , TaranovaOVet al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification . Nature466 , 1129 – 1133 ( 2010 ).
  • Belkina AC , DenisGV . BET domain co-regulators in obesity, inflammation and cancer . Nat. Rev. Cancer12 ( 7 ), 465 – 477 ( 2012 ).
  • Delmore JE , IssaGC , LemieuxMEet al. BET bromodomain inhibition as a therapeutic strategy to target c-Myc . Cell146 ( 6 ), 904 – 917 ( 2011 ).
  • Zhao X , LwinT , ZhangXet al. Disruption of the MYC-miRNA-EZH2 loop to suppress aggressive B-cell lymphoma survival and clonogenicity . Leukemia27 ( 12 ), 2341 – 2350 ( 2013 ).
  • Tolani B , GopalakrishnanR , PunjVet al. Targeting Myc in KSHV-associated primary effusion lymphoma with BET bromodomain inhibitors . Oncogene33 ( 22 ), 2928 – 2937 ( 2014 ).
  • Lockwood WW , ZejnullahuK , BradnerJEet al. Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins . Proc. Natl Acad. Sci. USA109 ( 47 ), 19408 – 19413 ( 2012 ).
  • Bhadury J , NilssonLM , Veppil MuralidharanSet al. BET and HDAC inhibitors induce similar genes and biological effects and synergize to kill in Myc-induced murine lymphoma . Proc. Natl Acad. Sci. USA111 ( 26 ), e2721 – e2730 ( 2014 ).
  • Heller G , SchmidtWM , ZieglerBet al. Genome-wide transcriptional response to 5-aza-2’-deoxycytidine and trichostatin a in multiple myeloma cells . Cancer Res.68 ( 1 ), 44 – 54 ( 2008 ).
  • Stewart DJ , NunezMI , JelinekJet al. Impact of decitabine on immunohistochemistry expression of the putative tumor suppressor genes FHIT, WWOX, FUS1 and PTEN in clinical tumor samples . Clin. Epigenetics6 ( 13 ), ( 2014 ).
  • Stewart DJ , IssaJP , KurzrockRet al. Decitabine effect on tumor global DNA methylation and other parameters in a Phase I trial in refractory solid tumors and lymphomas . Clin. Cancer Res.15 ( 11 ), 3881 – 3888 ( 2009 ).
  • Pichiorri F , PalumboT , SuhSSet al. Fhit tumor suppressor: guardian of the preneoplastic genome . Future Oncol.4 ( 6 ), 815 – 824 ( 2008 ).
  • Cui Z , LinD , ChengFet al. The role of the WWOX gene in leukemia and its mechanisms of action . Oncol. Rep.29 ( 6 ), 2154 – 2162 ( 2013 ).
  • Dayan S , O’KeefeLV , ChooAet al. Common chromosomal fragile site FRA16D tumor suppressor WWOX gene expression and metabolic reprograming in cells . Genes Chromosomes Cancer52 ( 9 ), 823 – 831 ( 2013 ).
  • Aqeilan RI , CroceCM . WWOX in biological control and tumorigenesis . J. Cell. Physiol.212 ( 2 ), 307 – 310 ( 2007 ).
  • Phuong NT1 , KimSK , LimSCet al. Role of PTEN promoter methylation in tamoxifen-resistant breast cancer cells . Breast Cancer Res. Treat.130 ( 1 ), 73 – 83 ( 2011 ).
  • Demokan S , ChuangAY , ChangXet al. Identification of guanine nucleotide-binding protein γ-7 as an epigenetically silenced gene in head and neck cancer by gene expression profiling . Int. J. Oncol.42 ( 4 ), 1427 – 1436 ( 2013 ).
  • Jamieson AC , MillerJC , PaboCO . Drug discovery with engineered zinc-finger proteins . Nat. Rev. Drug Discov.2 , 361 – 368 ( 2003 ).
  • Miller JC , TanS , QiaoGet al. A TALE nuclease architecture for efficient genome editing . Nat. Biotechnol.29 , 143 – 148 ( 2011 ).
  • Zhang H , NiuB , HuJFet al. Interruption of intrachromosomal looping by CCCTC binding factor decoy proteins abrogates genomic imprinting of human insulin-like growth factor II . J. Cell Biol.194 , 475 – 487 ( 2011 ).
  • Wei H , ZhouMM . Dimerization of a viral SET protein endows its function . Proc. Natl Acad. Sci. USA107 , 18433 – 18438 ( 2010 ).
  • Ma AN , WangH , GuoRet al. Targeted gene suppression by inducing de novo DNA methylation in the gene promoter . Epigenetics Chromatin7 , 1 – 11 ( 2014 ).
  • Wiznerowics M , JakobssonJSzulcJet al. The Kruppel-associated box repressor domain can trigger de novo promoter methylation during mouse early embryogenesis . J. Biol. Chem.282 , 34535 – 34541 ( 2007 ).
  • Hublitz P , AlbertM , PetersAH . Mechanisms of transcriptional repression by histone lysine methylation . Int. J. Dev. Biol.53 , 335 – 354 ( 2009 ).
  • Rice JC , BriggsSD , UeberheideBet al. Histone methyltransferases direct different degree of methylation to define distinct chromatin domains . Mol. Cell12 , 1591 – 1598 ( 2003 ).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.